Two way, two parallel groups, crossover study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid® (Angelini Pharma S.p.A.) at steady-state in 64 Healthy Volunteers.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Assessment of bioequivalence of two different formulations of trazodone hydrochloride tablets 150 mg
Timeframe: 5 days
Assessment of bioequivalence of two different formulations of trazodone hydrochloride tablets 150 mg
Timeframe: 5 days
Assessment of bioequivalence of two different formulations of trazodone hydrochloride tablets 150 mg
Timeframe: 5 days
Assessment of bioequivalence of two different formulations of trazodone hydrochloride tablets 300 mg
Timeframe: 5 days
Assessment of bioequivalence of two different formulations of trazodone hydrochloride tablets 300 mg
Timeframe: 5 days
Assessment of bioequivalence of two different formulations of trazodone hydrochloride tablets 300 mg
Timeframe: 5 days